TCR-gamma gene rearrangement with interstitial deletion within the TRGV2 gene segment is not detected in normal T-lymphocytes

TO THE EDITOR
Chromosomal translocations detected in T cell acute lymphoblastic leukemias (T-ALL) frequently involve chromosomal regions 14q11 and 7q35, where the genes that encode the T cell receptor ␣, ␦ and ␤ chains (TCRA, TCRD and TCRB) are located. Interestingly, none of the translocations hitherto described affect the T cell receptor ␥-chain locus (TCRG). Nevertheless, although there is no cloning data that demonstrate TCRG involvement, cytogenetic abnormalities involving 7p14-15, the chromosomal site to which the TCRG locus has been ascribed, have been described in patients with T-ALL and lymphoblastic lymphoma. 1 We have analyzed the molecular organization of the TCRG gene in 40 cases of T-ALL and have found a case (patient T14), where neoplastic cells were positive for nuclear TdT and CD7, CD2, CD1, CD4 and CD8 surface antigens but negative for CD3, Ia and CD10 antigens. Southern blot analysis with probes derived from the V␥ and J␥ gene segments showed that
Figure 1
Southern blot analysis of DNA from patient T14 with the pH60 probe. (a) DNA digested with the restriction enzyme EcoRI. (b) DNA digested with the restriction enzyme KpnI. (c, control) . The size of the EcoRI germline fragments are 3.2 and 1.5 kb. 4 The size of the KpnI germline fragments are 16 and 9 kb. 5 The nomenclature used to define the germ line fragments is according to Quertermous et al. the leukemic cells of this patient carry two rearranged alleles. DNA digestion with the restriction enzyme EcoRI and hybridization with the pH60 probe that recognizes the J1 and J2 containing fragments 2 showed a 2.2 kb non-germline fragment that might be explained as a consequence of a TRGV5-TRGJ2 rearrangement, and a 0.8 kb fragment the size of which does not correspond to any known rearranged fragment of the TCRG gene ( Figure 1 ). [3] [4] [5] [6] Analysis of the patient's DNA after digestion with the restriction enzyme KpnI and hybridization with the pH60 probe showed the presence, in addition to the known 1.8 kb rearranged fragment, of a novel 1.6 kb rearranged fragment ( Figure 1 ). Hybridization with the pBV␥I probe 7 demonstrated that a segment from the V␥I family was also involved in this new rearrangement (data not shown).
To characterize the abnormal rearrangement, we performed reverse PCR, 8 after circularization of EcoRI-digested DNA, with a pair of primers designed in opposite direction. TRGJ-BACK ACGGAG 3′). 9 Sequencing of the PCR product indicated that the fragment consisted of sequences from the TRGV2 and TRGJ2 segments. Standard PCR with primers TRGV1-FOR (21-mer (13-38): 5′ GGTGCTTCTAGCTTTCCTGTC 3′) 10 and TRGJ-BACK amplified a 342 bp fragment that was smaller than the one predicted. The complete sequencing of both PCR fragments demonstrated a 170 bp deletion at the 3′ end of the TRGV2 region (Figure 2a) .
A rearrangement similar to this has been previously reported in another two cases of T-ALL. 11, 12 Significantly, the sequencing of the amplified fragment show that the deletion breakpoint in the V␥2 gene segment occurred at the same position in the case that we report and in patient AA 11 and three nucleotides downstream of the site in patient TM 12 ( Figure 2a) . Furthermore, the J␥2.3 sequence in our case is similar to that of the case described by Carr et al 12 ( Figure 2a ). Detailed analysis of the nucleotide sequence in the vicinity of the deletion breakpoints demonstrated that the rearrangement takes place immediately upstream of sequences that are closely related to the known heptamer-nonamer recombination signal sequences (Figure 2a) . Moreover, analysis of the sequences involved in the rearrangement revealed the presence of non-germline sequences (N-region) in the V-J junction. These findings and the fact that there is an N-region in the other two published cases, further suggest the involvement of recombinase activity in the generation of this unusual rearrangement. Although a high level of homology was found between the genes of the V␥I family, analysis of its sequences revealed that the cryptic recombination signal sequences (RSS) were only present in the TRGV2 segment. This may explain why this type of rearrangement with interstitial deletion only involves this V␥ segment.
It is known that the TCRG gene is rearranged in a high percentage of B-ALL. In order to better understand the meaning of this arrangement we performed PCR analysis of 70 cases of B-ALL but failed to detect the rearrangement with interstitial deletion of the TRGV2 segment in any of the cases included in our study. Moreover, a review of the literature also failed to reveal any case of B-ALL that presents the rearrangement here described.
To analyze the incidence of this rearrangement in normal lymphoid tissues we amplified, by PCR, different DNA samples from fetal spleen, fetal liver, 22-day fetal thymus, adult and fetal bone marrow, adult peripheral blood, tonsils, appendix, and CD34
, and CD4 − CD8 − thymocytes using primers TRGV1-FOR and TRGJ-BACK. All samples analyzed showed fragments resulting from the amplification of the classical V␥I-J␥1/2 rearrangements. However, none of them had a PCR product of the size of the TCRG gene rearrangement with interstitial deletion (Figure 2b) .
The fact that this rearrangement is only detected in T-ALL suggests that it is specific to leukemic T cells and might be a consequence of a derailment in the recombinase machinery similar to that responsible for chromosomal translocations in T-ALL. Nevertheless, we cannot exclude that this rearrangement occurs during normal T lymphocyte development and that it becomes prominent because the clone has expanded as a result of the leukemic transformation. In this sense, it is noteworthy that the putative transcript generated as a consequence of this rearrangement is out of frame in all three cases, indicating that the gene is non-functional. This could help to explain the absence of normal T lymphocytes bearing this rearrangement.
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